← Back to Search

Behavioral Intervention

Mobile Gaming App for HIV/AIDS Medication Adherence

N/A

Waitlist Available

Led By Laura Whiteley, MD

Research Sponsored by Rhode Island Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 12 weeks, 24 weeks, 36 weeks, 48 weeks

Awards & highlights

Study Summary

This trial will test a new intervention to improve adherence to HIV medications and treatment for youth. The intervention includes a mobile gaming app that is integrated with a 7-day electronic medication device and text messages.

Who is the study for?

This trial is for English-speaking youth living with HIV who have started or restarted antiretroviral therapy (ART) in the last three months. Participants must have access to a smartphone, be able to consent, and not be involved in other HIV-related studies. They should also have a detectable viral load.Check my eligibility

What is being tested?

The study tests a mobile gaming app designed to improve ART adherence among youth. The game integrates with an electronic medication device and sends text messages, aiming to make treatment more engaging and monitor progress.See study design

What are the potential side effects?

Since this intervention involves using a mobile app rather than a drug, traditional side effects are not expected. However, participants may experience increased screen time which could affect sleep patterns or cause eye strain.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 12 weeks, 24 weeks, 36 weeks, 48 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 12 weeks, 24 weeks, 36 weeks, 48 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 12 weeks, 24 weeks, 36 weeks, 48 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change from Baseline HIV-1 Viral Load at 48 weeks

Secondary outcome measures

Self-reported Medication Adherence

Self-reported Missed ARV Doses (1 Month)

Self-reported Missed ARV Doses (1 week)

Other outcome measures

Antiretroviral Therapy Treatment Knowledge

HIV Treatment Knowledge Scale

HIV Treatment Self-Efficacy

+4 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Multilevel Gaming AdherenceExperimental Treatment1 Intervention

Participants in the intervention arm will receive Multilevel Gaming Adherence Intervention. Participants receive Battle Viro on their mobile phones, an electronic pill monitoring device, and, for 24 weeks, game-related text messages guided by medication adherence data (collected from an electronic pill monitoring device).

Group II: Treatment as Usual +Active Control1 Intervention

TAU+ participants will receive the Treatment As Usual + intervention, which includes receiving a non-HIV related mobile game and an electronic pill monitoring device.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Emory UniversityOTHER

1,636 Previous Clinical Trials

2,560,473 Total Patients Enrolled

Rhode Island HospitalLead Sponsor

260 Previous Clinical Trials

71,634 Total Patients Enrolled

University of Mississippi Medical CenterOTHER

173 Previous Clinical Trials

194,987 Total Patients Enrolled

Media Library

Multilevel Gaming Adherence Intervention (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT03760211 — N/A

Medication Adherence Research Study Groups: Multilevel Gaming Adherence, Treatment as Usual +

Medication Adherence Clinical Trial 2023: Multilevel Gaming Adherence Intervention Highlights & Side Effects. Trial Name: NCT03760211 — N/A

Multilevel Gaming Adherence Intervention (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03760211 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

In which geographical areas is this clinical experiment being conducted?

"At this time, the clinical trial is enrolling patients from 4 different medical centres; these include Boston Medical Center in Massachusetts, Emory University in Georgia, and University of Mississippi Medical Center in Jackson."

Answered by AI

Are recruitment of participants for this investigation still ongoing?

"Referring to clinicaltrials.gov, this particular trial is no longer accepting participants; the initial post was made on November 1st 2019 and the last update occurred in April 8th 2022. Nevertheless, there are currently 582 other studies actively recruiting patients."

Answered by AI

Am I eligible to participate in this clinical research study?

"This study seeks 100 individuals aged 15 to 30 with HIV and on antiretroviral therapy (ART). In addition, participants must have access to a smartphone for the entire duration of the trial, be uninvolved in any other related studies, started or re-started ART within 3 months before enrolling, capable of consent/assent without cognitive issues or medical impairments, and living with HIV."

Answered by AI